�鶹��ýӰ��

Oncology/Hematology >

Lung Cancer

News, opinions and meeting coverage in oncology/hematology.

'Unsolved Mysteries' on Display at AACR

Large, diverse program reflects rapid pace of advancement

ACS: E-Cigarettes OK for Smoking Cessation ... with Caveats

Short period of dual use OK, if goal is to quit

Freezing Metastatic Lung Tumors Feasible

Provides low morbidity alternative

Lung Biopsies for Genetic Info Appear Safe

Low rate of complications, no deaths

Weather Not a Factor in Pneumothorax Risk with Lung Biopsy

No relationship seen between complications and atmospheric conditions

Shared Decision-Making Strategies for Lung Ca Screening Get High Marks

Patient satisfaction high with physician-led and web-based approaches

Vince DeVita’s Oncology Opus

Medicine and music share center stage in storied career

New Standard for ALK-Positive NSCLC

Dramatic PFS, CNS benefits with alectinib

Genomic Testing Helps Cancer Patients -- When Results are Used

Also, liquid biopsy can ID drug-responsive tumors

Dacomitinib Sets PFS Record in Phase III NSCLC Trial

Next-gen EGFR inhibitor wins head-to-head battle with gefitinib, at least for efficacy

Immunotherapy Shows Promise in Tough-to-Treat Mesothelioma

Outcomes improved with nivolumab alone or with ipilimumab in pretreated patients

Advanced Ca Patients Benefit from Online Symptom Reports

Patient-reported outcomes tied to increased survival

Novel Agent Shows Antitumor Activity in TRK-Fusion Cancers

Tumor genetics define treatment approach in early-stage trials

Asthma Biologic, Rally Among ATS Highlights

Attendees to organize on Capitol Hill; will also hear benralizumab phase III results

ESTRO: Tumor-Adapted RT Lowers Pneumonitis in Lung Cancer

Selected presentations from the European RT meeting

MSK Cancer Alliance: Mainly About Medicine

Bi-directional relationship strengthens regional cancer care

Fewer 'Nails in the Coffin' as Smoking Rate Declines

But "smoke-free" remains aspiration, not fact

Is Keytruda Better than Opdivo?

Trial results begin to suggest an advantage

Fatal Illness Contracted From Bagpipes

Playing 'the pipes' can be deadly

Novel App Seems to Extend Lung Cancer Survival

Web app offers early detection of relapse, complications between healthcare visits

Novel Agent Offers Hope in Small Cell Lung Cancer

Antibody-drug conjugate Rova-T looks good, but in very early trial

Palliative Care Benefits Caregivers, Too

Better QoL, less depression among 'downstream' effects

Slippery Slope: A Targeted Therapy That Misses the Mark?

Afinitor racks up FDA approvals, but where is the evidence?

Post-Op CT Scans May Improve Lung Cancer Survival

4-year survival rate up 12 percentage points in patients having scans

Part 2: Oncologists Weigh In on PBS Cancer Documentary

Six specialists share their impressions of Ken Burns' cancer opus.

Scoring System for Lung Cancer Screening Debuts

Radiologists to get tools for grading suspicious lesions.

That's Not Chronic Lyme, It's Cancer

Three case reports demonstrate the risks of "assuming that patients have chronic Lyme disease."

Friday Feedback: Zero-Tolerance Employment Smoking Bans?

Should hospitals, schools, and companies refuse to hire smokers for teachers and healthcare providers?

ASCO: Antibody Adds 6 Weeks to Squamous NSCLC Survival

CHICAGO -- The novel anti-EGFR monoclonal antibody necitumumab modestly improved survival in squamous non-small cell lung cancer (NSCLC) in a pivotal trial, but many called the effect too small to count.

Radiation Safe in Unbiopsied Lung Cancer

CHICAGO -- Treating people with stereotactic body radiation for suspected -- but unbiopsied -- lung cancers appears to allow for acceptable local control of the disease with low toxicity, researchers reported here.

'Nose Knows' Devices Not Ready for Clinic

BARCELONA -- Within a decade, doctors may be able to diagnose cancer, asthma, and tuberculosis simply by having an electronic nose analyze a person's breath, researchers reported here.

Medicare to Pay for More FDG-PET Scans

WASHINGTON -- Up to three scans using 18F-fluorodeoxyglucose-enhanced positron emission tomography technology can be covered by Medicare for oncology treatment planning, the Centers for Medicare and Medicaid Services said.

ASCO: Targeted Agent Has Slim NSCLC Benefit

CHICAGO -- The novel kinase inhibitor nintedanib may slightly delay relapse of non-small cell lung cancer when added to chemotherapy, with perhaps greater benefit in adenocarcinomas, the LUME-Lung 1 trial showed.

Adult Lungs Can Sprout New Growth

The lungs may have greater capacity for regeneration in adults than thought, according to a case report of new growth after lung cancer resection.

Doctors Say 45 Common Tests 'Overused'

Nine specialty groups have listed tests and treatments that are frequently overused, such as antibiotics for sinus attacks and CT scans for low back pain, in the first phase of a long-term project.

Data Misreported in Studies of CT Lung Cancer Screening

NEW YORK -- Key data were incorrectly reported in two recent publications by the International Early Lung Cancer Action Project (I-ELCAP), according to the investigators, possibly undermining their positive conclusions.

ASCO: Platinum-Taxane Regimen No Benefit for Thymoma or Thymic Carcinoma

CHICAGO -- For treatment-naive advanced thymoma or thymic carcinoma, carboplatin (Paraplatin) and paclitaxel (Taxol) failed to achieve response rates approaching those reported in published trials of athracycline-based regimens.

Radiologists Take FDA Warning on Lung Ablation in Stride

ROCKVILLE, Md. -- The FDA's recent warning about deaths caused by radiofrequency ablation of lung tumors was more a note of caution than a mortal blow to the procedure, said interventional radiologists experienced with the technique.

Lung Cancer Risk of One Marijuana Joint a Day Equals Daily Pack of Cigarettes

WELLINGTON, New Zealand -- Smoking a single marijuana joint may be as carcinogenic to the lung as 20 tobacco cigarettes, researchers here calculated.

ASCO: High Dose Pemetrexed (Alimta) Fails to Increase Survival in NSCLC

CHICAGO -- Increasing the dose of pemetrexed (Alimta) to 900 mg/m2 did not improve outcome for patients with advanced non-small cell lung cancer (NSCLC), but did slightly increase toxicity, researchers found.

…

9